Assembly Biosciences, Inc.
ASMB- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001426800
No open-market purchases or sales by Assembly Biosciences, Inc. insiders were filed in the last 90 days; 92 institutions reported holding it in 13F filings for Q2 2026, worth $514.8M in total; no superinvestor holds it.
13F holders, Q3 2023
Institutional positions in Assembly Biosciences, Inc. as of Sep 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 32
- 0 vs. Q2 2023
- Shares held
- 9.74M
- −727.2K (−6.9%) vs. Q2 2023
- Total value
- $8.62M
- −$3.42M (−28.4%) vs. Q2 2023
- New holders
- 2
- 3 more added
- Sold out
- 2
- 12 more reduced
Compare with Q2 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ASMB on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 92 | $514.8M |
| Q1 2026 | 75 | $381.5M |
| Q4 2025 | 69 | $466.7M |
| Q3 2025 | 57 | $324.9M |
| Q2 2025 | 33 | $57.1M |
| Q1 2025 | 37 | $30.4M |
| Q4 2024 | 35 | $50.3M |
| Q3 2024 | 30 | $15.6M |
| Q2 2024 | 27 | $16.1M |
| Q1 2024 | 24 | $8.68M |
| Q4 2023 | 45 | $7.12M |
| Q3 2023 | 32 | $8.62M |
| Q2 2023 | 32 | $12.0M |
| Q1 2023 | 38 | $11.1M |
| Q4 2022 | 40 | $18.4M |
| Q3 2022 | 50 | $27.2M |
| Q2 2022 | 54 | $36.1M |
| Q1 2022 | 54 | $39.3M |
| Q4 2021 | 62 | $54.3M |
| Q3 2021 | 65 | $79.0M |
| Q2 2021 | 91 | $105.1M |
| Q1 2021 | 107 | $133.6M |
Institutions, Q3 2023
Shares, value and share of portfolio for each institution holding Assembly Biosciences, Inc.; share changes are against Q2 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vanguard Group Inc | 2,239,996 | $1.98M | 0.00% | −33,766−1.5% | Reduced |
| Satter Management Co., L.P. | 2,227,500 | $1.97M | 3.37% | 00.0% | Unchanged |
| Millennium Management LLC | 1,410,027 | $1.25M | 0.00% | −36,788−2.5% | Reduced |
| BlackRock Inc. | 1,062,687 | $940.5K | 0.00% | −7,637−0.7% | Reduced |
| Renaissance Technologies LLC | 493,691 | $437.0K | 0.00% | −204,309−29.3% | Reduced |
| Geode Capital Management, LLC | 485,264 | $429.6K | 0.00% | −22,385−4.4% | Reduced |
| Hudson Bay Capital Management LP | 399,578 | $353.6K | 0.00% | −426,677−51.6% | Reduced |
| Federated Hermes, Inc. | 341,858 | $302.5K | 0.00% | 00.0% | Unchanged |
| Bridgeway Capital Management, LLC | 174,000 | $154.0K | 0.00% | 00.0% | Unchanged |
| State Street Corp | 145,335 | $128.6K | 0.00% | 00.0% | Unchanged |
| Citadel Advisors LLC | 138,564 | $122.6K | 0.00% | +44,916+48.0% | Added |
| FMR LLC | 136,912 | $121.2K | 0.00% | −3,606−2.6% | Reduced |
| Northern Trust Corp | 108,116 | $95.7K | 0.00% | 00.0% | Unchanged |
| Acadian Asset Management LLC | 83,470 | $73.0K | 0.00% | −30,384−26.7% | Reduced |
| Franklin Resources Inc | 65,392 | $57.9K | 0.00% | −17,253−20.9% | Reduced |
| Morgan Stanley | 44,725 | $39.6K | 0.00% | −68−0.2% | Reduced |
| Barclays PLC | 35,928 | $31.8K | 0.00% | 00.0% | Unchanged |
| Charles Schwab Investment Management Inc | 32,452 | $28.7K | 0.00% | 00.0% | Unchanged |
| XTX Topco Ltd | 25,237 | $22.3K | 0.00% | +25,237 | New |
| Commonwealth Equity Services, LLC | 17,885 | $16.0K | 0.00% | −263−1.4% | Reduced |
| Bank of New York Mellon Corp | 15,866 | $14.0K | 0.00% | 00.0% | Unchanged |
| RBF Capital, LLC | 14,741 | $13.0K | 0.00% | 00.0% | Unchanged |
| Two Sigma Advisers, LP | 13,000 | $11.5K | 0.00% | −1,900−12.8% | Reduced |
| HSBC Holdings PLC | 11,413 | $10.2K | 0.00% | 00.0% | Unchanged |
| Engineers Gate Manager LP | 10,071 | $8.91K | 0.00% | 00.0% | Unchanged |
| Rhumbline Advisers | 2,402 | $2.12K | 0.00% | 00.0% | Unchanged |
| Baker Avenue Asset Management, LP | 1,000 | $885 | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 500 | $443 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 384 | $340 | 0.00% | +9+2.4% | Added |
| JPMorgan Chase & Co | 155 | $137 | 0.00% | +60+63.2% | Added |
| Qube Research & Technologies Ltd | 43 | $38 | 0.00% | +43 | New |
| BNP Paribas Arbitrage, SA | 32 | $28 | 0.00% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −12,067−100.0% | Sold out |
| Royal Bank of Canada | 0 | $0 | 0.00% | −331−100.0% | Sold out |